Showing results (1061-1070 of 1,104) with videos related to
Sort By:
Pageof 111
The Lancet. Oncology|January 21, 2015
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 studyCharles J Ryan, Matthew R Smith, Karim Fizazi, et al.Science Translational Medicine|December 3, 2011
Personalized oncology through integrative high-throughput sequencing: a pilot studySameek Roychowdhury, Matthew K Iyer, Dan R Robinson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2014
Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant studyMary-Ellen Taplin, Bruce Montgomery, Christopher J Logothetis, et al.Proceedings of the National Academy of Sciences of the United States of America|June 17, 2015
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3Ahmad Salameh, Alessandro K Lee, Marina Cardó-Vila, et al.Proceedings of the National Academy of Sciences of the United States of America|November 4, 2011
Vascular ligand-receptor mapping by direct combinatorial selection in cancer patientsFernanda I Staquicini, Marina Cardó-Vila, Mikhail G Kolonin, et al.BMJ Open|April 28, 2023
Protocol for a bandit-based response adaptive trial to evaluate the effectiveness of brief self-guided digital interventions for reducing psychological distress in university students: the Vibe Up studyKit Huckvale, Leonard Hoon, Eileen Stech, et al.Iscience|June 15, 2026
Targeting arginine metabolism overcomes chemotherapy resistance in aggressive-variant prostate cancersElavarasan Subramani, Patrick G Pilié, Rebecca Slack-Tidwell, et al.The New England Journal of Medicine|May 27, 2011
Abiraterone and increased survival in metastatic prostate cancerJohann S de Bono, Christopher J Logothetis, Arturo Molina, et al.Current Vascular Pharmacology|June 6, 2018
Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical TrialKallirroi I Kalantzi, Ioannis V Ntalas, Vasileios G Chantzichristos, et al.The Lancet. Public Health|November 1, 2024
Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health recordsRobert A Fletcher, Patrick Rockenschaub, Brendon L Neuen, et al.Pageof 111